Results 151 to 160 of about 1,293,842 (319)

A Rare Case of Synchronous Multiple Primary Malignancies of the Pancreas, Skin, and Thyroid. [PDF]

Case Rep Oncol Med
Barsoum M, Pepeljugoski CA.
europepmc   +1 more source

Primary malignant neoplasms of nerves (Malignant neurilemomas) in patients without manifestations of multiple neurofibromatosis (von Recklinghausen's disease) [PDF]

, 1963
Anthony N. D’Agostino, Edward H. Soule, Ross H. Miller   +2 more
openalex   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Synchronous Primary Gallbladder Cancer and Ipsilateral Renal Cell Carcinoma: A Case Report. [PDF]

Cureus
Alobaidi SK.
europepmc   +1 more source

PO-081 Multiple primary malignant neoplasms of head and neck

, 2019
Z. Fèssi, N. Fourati, W. Mnejja, Wala Ben Kridis, Ilhem Charfeddine, Afef Khanfir, W. Siala, J. Daoud   +7 more
openalex   +1 more source

Concordant clear cell “mesonephric” carcinoma of the bladder and lung adenocarcinoma with clear cell features – multiple primaries versus metastatic neoplasms: a case report [PDF]

, 2017
Sarmad Jassim, Amer Khiyami, Jane Nguyen, Santhi Ganesan, Joseph F. Tomashefski, Joram Sawady   +5 more
openalex   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Integrated diagnostic evaluation of multiple malignant neoplasms via ^99mTc-MDP three-phase bone imaging: A case report. [PDF]

Oncol Lett
Lian JY, Lu JL, Zheng HY, Yuan SX, Zhang JS.   +4 more
europepmc   +1 more source

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Risk Factors beyond Chemotherapy Exposure for Secondary Myeloid Neoplasms after Hematologic Cancers: A SEER-Based Study. [PDF]

Cancer Res Commun
Singh A, Hahn T, Mishra R, Herr MM, Thota S.   +4 more
europepmc   +1 more source